Home
>
National Drug Code (NDC)
>
Maxidex
Maxidex - 0998-0615-05 - (dexamethasone)
Drug Information of Maxidex
| Product NDC: | 0998-0615 |
| Proprietary Name: | Maxidex |
| Non Proprietary Name: | dexamethasone |
| Active Ingredient(s): | 1 mg/mL & nbsp; dexamethasone |
| Administration Route(s): | OPHTHALMIC |
| Dosage Form(s): | SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Maxidex
| Product NDC: | 0998-0615 |
| Labeler Name: | Alcon Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA013422 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19660515 |
Package Information of Maxidex
| Package NDC: | 0998-0615-05 |
| Package Description: | 5 mL in 1 BOTTLE, PLASTIC (0998-0615-05) |
NDC Information of Maxidex
| NDC Code | 0998-0615-05 |
| Proprietary Name | Maxidex |
| Package Description | 5 mL in 1 BOTTLE, PLASTIC (0998-0615-05) |
| Product NDC | 0998-0615 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | dexamethasone |
| Dosage Form Name | SUSPENSION |
| Route Name | OPHTHALMIC |
| Start Marketing Date | 19660515 |
| Marketing Category Name | NDA |
| Labeler Name | Alcon Laboratories, Inc. |
| Substance Name | DEXAMETHASONE |
| Strength Number | 1 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
